BioNTech plans six new phase 3 oncology trials in 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. SPCX
7. AVGO
8. HD
9. BJ
10. BABA

Go back to BioNTech plans six new phase 3 oncology trials in 2026
(NASDAQ: BNTX) Delayed: 116.57 +5.68 (5.12%)
Previous Close $110.89    52 Week High $ 
Open $110.92    52 Week Low $ 
Day High $120.33    P/E N/A 
Day Low $110.89    EPS $ 
Volume 2,960,713